A Primary Prevention Trial to Strengthen Child Attachment in a Native Community

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2019

Study Completion Date

June 30, 2021

Conditions
Parent-child Interaction
Interventions
BEHAVIORAL

PFR Group

"The intervention consists of delivering the Promoting First Relationship (PFR) program. PFR comprises 10 sessions and lasts approximately 12 weeks. Each session begins with a brief discussion and education on the target topic for that week . Then 20 minutes is spent on video recording a structured interaction between the caregiver and child or viewing the previous session's recording and engaging in reflective discussion about successful caregiving strategies and child's response to caregiver behavior (alternating weeks). Trained PFR specialists who are community members use the 5 consultation strategies, labeled Joining, Positive Feedback, Instructive Feedback, Reflective Questions and Comments, and Instruction with Handouts."

BEHAVIORAL

Resource & Referral Group

The Resource \& Referral program consists of 1) an initial needs assessment to determine if the enrolled family has any unmet needs (housing, financial, health, mental health, etc…), 2) a tailored resource and referral packet will be mailed to the participant with the most important referrals marked, 3) a follow-up call will be made two weeks after mailing the packet to verify that the participant has received it, and 4) a second follow-up call will be made three months after the initial session, to assess types of services actually received, barriers to receiving services, and reassessing resources needed and providing additional referrals if needed.

Trial Locations (1)

57625

MBIRI, Eagle Butte

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

University of Washington

OTHER

NCT02139332 - A Primary Prevention Trial to Strengthen Child Attachment in a Native Community | Biotech Hunter | Biotech Hunter